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1,25 dihydroxyvitamin D (1,25(OH)2D), the active metabolite of vitamin D, and calcium
regulate epidermal differentiation. 1,25(OH)2D exerts its effects through the vitamin D
receptor (VDR), a transcription factor in the nuclear hormone receptor family, whereas
calcium acts through the calcium sensing receptor (Casr), a membrane bound member
of the G protein coupled receptor family. We have developed mouse models in which
the Vdr and Casr have been deleted in the epidermis (epidVdr−/− and epidCasr−/−).
Both genotypes show abnormalities in calcium induced epidermal differentiation in
vivo and in vitro, associated with altered hedgehog (HH) and β–catenin signaling that
when abnormally expressed lead to basal cell carcinomas (BCC) and trichofolliculomas,
respectively. The Vdr−/− mice are susceptible to tumor formation following UVB or
chemical carcinogen exposure. More recently we found that the keratinocytes from these
mice over express long non-coding RNA (lncRNA) oncogenes such as H19 and under
express lncRNA tumor suppressors such as lincRNA-21. Spontaneous tumors have not
been observed in either the epidVdr−/− or epidCasr−/−. But in mice with epidermal specific
deletion of both Vdr and Casr (epidVdr−/−/epidCasr−/− [DKO]) tumor formation occurs
spontaneously when the DKO mice are placed on a low calcium diet. These results
demonstrate important interactions between vitamin D and calcium signaling through
their respective receptors that lead to cancer when these signals are disrupted. The
roles of the β–catenin, hedgehog, and lncRNA pathways in predisposing the epidermis
to tumor formation when vitamin D and calcium signaling are disrupted will be discussed.
Keywords: vitamin D receptor, calcium sensing receptor, squamous cell carcinoma, long non coding RNA, UVB,
hedgehog, β–catenin
INTRODUCTION
Skin cancer is the most common form of cancer with an incidence estimated to be over 5 million
skin cancers per year in the United States and rising (American Cancer Society, data available at
http://www.cancer.org.cancer, April, 2016 update). Most of these (80%) are basal cell carcinomas
(BCC). Squamous cell carcinomas (SCC) make up another 16% and melanomas another 4%.
Sunlight, in particular the UVB part of the spectrum (up to 5% of the UV light reaching earth
depending on the zenith angle of the sun associated with time of day and season), is the major
etiologic agent for these cancers. UVB (280–320 nm) is absorbed by DNA in the epidermis
resulting in mutations identified as cyclobutane pyrimidine dimers (CPDs) and pyrimidine (6–4)
pyrimidone photoproducts (6–4 PP) that lead to C to T or CC to TT mutations if not repaired.
These are commonly referred to as the UVB “signature” lesion (Freeman et al., 1989; Hussein,
2005). On the other hand UVA (320–400 nm), comprising 95% of the UV light reaching earth,
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is capable of penetrating into the dermis and does its DNA
damage primarily by oxidative processes (e.g., 8 hydroxy 2′
deoxyguanosine production), but CPDs may be produced at
higher levels (Besaratinia et al., 2005). On the other hand
UVB is required for vitamin D3 production converting 7-
dehydrocholesterol levels in the skin to pre vitamin D3, which
then isomerizes to vitamin D3. White males with class III
pigmentation require 18 mJ/cm2 UVB exposure for vitamin
D3 production, (Matsuoka et al., 1989), a dose not likely to
lead to tumors in most individuals. However, the efficiency of
vitamin D production by solar radiation is less than that of
monochromatic UVB in part due to the UVA portion of solar
radiation that influences the ratio of pre D3 to lumisterol3
produced and that may contribute to tumor formation over
and above that of UVB (MacLaughlin et al., 1982; Agar et al.,
2004). Vitamin D3 production is not the only metabolic step
of which the skin is capable. Both the further conversion to
25OHD3 (via Cyp27A1 and Cyp2R1) and then to its active
metabolite 1,25(OH)2D3 (via Cyp27b1) (Bikle et al., 1986) take
place. This latter step is promoted byUVR (Muthusamy and Piva,
2009), perhaps by stimulation of the expression of cytokines such
as TNF (Bikle et al., 1991). Moreover the vitamin D receptor
(VDR) is expressed in both melanocytes (Colston et al., 1982)
and keratinocytes (Pillai et al., 1988) and have been shown to
respond to 1,25(OH)2D3 by a reduction in proliferation and
promotion of differentiation (Colston et al., 1981; Bikle, 2012b).
A key rationale for our studies in the protective role of calcium
and vitamin D signaling in UVR induced skin cancer is that
the 1,25(OH)2D3 produced in the skin under the influence of
UVR provides protection against UVB and likely UVA induced
tumors, a rationale supported by epidemiologic evidence that
suggests benefit of low dose UVR. For example, modest increases
in UVB appeared to be protective against skin cancer in a
meta analysis of 10 US studies (Armstrong and Kricker, 2001),
although higher doses of UVB were not protective. Moreover,
no significant correlation in SCC incidence was observed in
association with time spent outdoors in an Australian population
study (English et al., 1998). In a multicenter European study
Rosso et al. (1996) identified a threshold of 70,000 accumulated
hours of sunshine below which an increase in SCC was not
observed, although the threshold for BCC was lower. Thus, the
clinical evidence is at least supportive if not definitive for a
protective role of low dose UVB, mediated we submit via vitamin
D production. Although a similar case has not been made for
calcium in epidermal tumor formation, the epidemiologic data
demonstrating protection against colorectal cancer by diets high
in calcium and vitamin D is substantial (Garland et al., 1985;
Chakrabarty et al., 2005), and as will be discussed later in this
article, the role of calcium appears to be synergistic with that of
vitamin D.
REGULATION OF KERATINOCYTE
PROLIFERATION AND DIFFERENTIATION
BY CALCIUM AND 1,25(OH)2D
Calcium and 1,25(OH)2D are critical for keratinocyte
differentiation. Calcium concentrations below 0.07mM
promote proliferation, whereas increasing the extracellular
calcium concentration (Cao) above 0.1 mM (calcium switch)
induces differentiation. Among the changes are the translocation
of proteins such as E-cadherin to the membrane to form the
E-cadherin/catenin complex (adherens junctions). Proteins
associated with this complex include phosphatidyl inositol
3 kinase (PI3K), various catenins including β-catenin, and
phosphatidyl inositol 4-phosphate 5-kinase 1α (PIP5K1A).
These proteins in this complex mediate much of the ability of
calcium and vitaminD to promote differentiation (Tu et al., 2001,
2005; Xie et al., 2005, 2009; Xie and Bikle, 2007; Tu C. et al., 2008).
Other important proteins whose translocation to the membrane
promotes the differentiation process include the calcium sensing
receptor (Casr), phospholipase C-γ1 (Plcg1), and the Src family
of tyrosine kinases, the activation of which phosphorylate the
catenins facilitating their binding to E-cadherin to form the
E-cadherin/catenin complex. These changes then lead to the
sequential induction of proteins including keratins Krt1 and
Krt10 (Yuspa et al., 1989), profilaggrin (the precursor of filaggrin
[Flg]), involucrin (Ivl), and loricrin (Lor). These and other
proteins are cross linked into the insoluble cornified envelope
by the calcium induced transglutaminase 1 (Tgm1) (Thacher
and Rice, 1985; Hohl, 1990), the final step in the differentiation
process.
The Casr underlies the ability of the keratinocyte to respond to
calcium (Tu et al., 2004, 2011, 2012; Tu C. et al., 2008). The Casr
through the scaffold protein filamin activates the RhoA pathway
that in turn activates the src kinase family, which phosphorylate
the catenins, facilitating their binding to E-cadherin (Tu et al.,
2011). We cloned the Casr from keratinocytes (Oda et al., 1998)
and subsequently developed a mouse expressing a floxed form
of Casr (exon 7 encoding the entire transmembrane domain and
intracellular portion of the gene; Chang et al., 2008; Tu C. et al.,
2008). This enables us to delete the gene in the tissue of our
choice, in this case the keratinocyte where we demonstrated the
central role of Casr in calcium signaling within the keratinocyte
and its impact on differentiation (Tu C. et al., 2008; Tu et al.,
2012). Mice lacking the Casr develop a defective permeability
barrier due to abnormal production of essential lipids and
proteins required for barrier formation as well as a defective
innate immune response. Similar abnormalities develop in mice
with VDR or Cyp27b1 gene deletions. Moreover, deletion of
Casr also results in reduced expression of Vdr and Cyp27b1 (Tu
et al., 2012), likely contributing to the failure of the epidermis of
Casr deficient mice to differentiate normally. On the other hand
1,25(OH)2D induces the Casr (Canaff and Hendy, 2002). Just as
1,25(OH)2D/VDR inducesCasr, calcium/Casr is required forVdr
and Cyp27b1 expression, demonstrating the strong interaction
between calcium and vitamin D signaling in the skin with
respect to differentiation. Thus, the actions of 1,25(OH)2D/VDR
enhance the keratinocyte response to the prodifferentiating
actions of calcium (Ratnam et al., 1999), whereas the effect of
Casr in the expression of Vdr and Cyp27b1 (Tu et al., 2012)
enhances the prodifferentiating actions of 1,25(OH)2D (Su et al.,
1994). With respect to cancer, this synergistic interaction is an
important concept to which we will return.
The synergism between Casr and VDR is well-demonstrated
by the joint regulation of the expression of a number of
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genes by calcium and 1,25(OH)2D including the phospholipase
C (Plc) family members (Xie and Bikle, 1997) important
for differentiation, the processing of the lipids required for
permeability barrier formation (Oda et al., 2009), and the
enhancement of the innate immune response via induction
of toll like receptor 2 (TLR2) and its coreceptor CD14, that
initiate the innate immune response in skin leading to the
expression of defensins such as cathelicidin (Schauber et al.,
2007). Moreover, both calcium and 1,25(OH)2D inhibit genes
such as Myc (Matsumoto et al., 1990) and Ccnd1 (Bikle, 2011)
while inducing cell cycle inhibitors Cdnk1a (aka p21cip) and
Cdnk1b (aka p27kip), which contribute to the antiproliferative
actions of calcium and 1,25(OH)2D. The roles of calcium/Casr
and 1,25(OH)2D/VDR in immune regulation as well as in
proliferation and differentiation likely contribute to their roles in
protection of the skin against the development of skin cancer.
THE ROLES OF VDR AND Casr IN CANCER
PROTECTION
Zinser et al. (2002) made the first clear demonstration
of the predisposition to tumor formation in the skin of
mice lacking VDR. They administered the carcinogen 7, 12
dimethylbenzanthracene (DMBA) to Vdr null mice and wildtype
mice and found that nearly all the Vdr null mice developed
papillomas, whereas few if any of the wildtype mice did. Others
have confirmed these results (Indra et al., 2007). Moreover, Vdr
null mice have also been shown to be predisposed to tumor
formation following prolonged UVB exposure first by Ellison
et al. (2008) and subsequently by our own group (Teichert A.
E. et al., 2011). Following UVB both SCC and BCC develop, not
just papillomas. Part of this predisposition to tumor formation is
due to a defective DNA damage repair process (review in Bikle,
2012a). The appearance of BCC suggested that the hedgehog
(HH) signaling pathway was involved, as mutations in this
pathway underlie essentially all BCC (Aszterbaum et al., 1998).
However, skin lacking VDR also results in BCC when β–catenin
signaling is increased (Pálmer et al., 2008). Thus, we became
interested in the interacting roles of HH and β-catenin signaling
in tumor suppression by VDR, a subject to which I will return.
When we knocked out both Vdr and Casr in keratinocytes
(epidVdr−/−/epidCasr−/−, DKO), tumors developed
spontaneously, something that we had not observed in
mice in which either gene was deleted by itself (Bikle et al.,
2015). In this case the tumors were SCC. Colorectal cancer
provides a good model for the development of skin tumors in
that abnormalities in calcium, vitamin D and β-catenin signaling
have also been implicated in the development of colorectal
cancer with human colorectal cancer cell lines (Chakrabarty
et al., 2003, 2005; Bhagavathula et al., 2007; Liu et al., 2010;
Wang et al., 2010). A frequently used model involves a mutated
Apc resulting in increased Wnt/β-catenin signaling (Arimura
et al., 2009). Activation of the Wnt/β-catenin pathway increases
proliferation and reduces apoptosis, whereas inhibition of this
pathway has the reverse effect (Varnat et al., 2009). As it does
in keratinocytes calcium via the Casr blocks the translocation
of β-catenin to the nucleus in part by increasing its binding
to the E-cadherin/catenin complex in the membrane, thus
blocking its transcriptional activity (Chakrabarty et al., 2003).
Like the situation in keratinocytes, 1,25(OH)2D synergizes with
calcium in these actions by inducing the expression of Casr
(Chakrabarty et al., 2005), increasing the expression of the
cell cycle inhibitors Cdkn1a and Cdkn1b, and inhibiting the
expression of Myc, Ccnd1, survivin (Birc5), and thymidylate
synthase (Tyms; Bhagavathula et al., 2007; Liu et al., 2010).
In addition to its stimulation of E-cadherin/catenin complex
formation, thus limiting the access of β-catenin to the nucleus,
1,25(OH)2D induces an inhibitor of Wnt //β-catenin signaling,
dickkopf 1 (Dkk1; Pendas-Franco et al., 2008). Our studies in
which Casr was deleted from the intestinal epithelial cell (Rey
et al., 2011) demonstrated hyperproliferation in these cells.
This was accompanied by increased localization of β–catenin
in the nuclei signifying activation of β-catenin signaling. Again
comparable to that shown in the skin, mice lacking Vdr in the
intestinal epithelium were predisposed to carcinogen induced
tumor formation (Byers et al., 2011). Whether deleting both Vdr
and Casr will lead to spontaneous colorectal tumors remains to
be tested.
1,25(OH)2D has also been shown to be protective against
UVA induced oxidative induced mutations in DNA (Gordon-
Thomson et al., 2012). UVA induces reactive oxygen species
(ROS) such as superoxide anion (O−2 ), hydrogen peroxide, and
hydroxyl radicals as well as nitric oxide (NO) via stimulation
of NO synthase. NO combines with O−2 to form peroxynitrite
that causes oxidative and nitrative modifications of DNA bases
such as 8 oxo 2 deoxyguanosine (D’Orazio et al., 2013). These
UVA fingerprint lesions along with UVB fingerprint lesions have
been found in human SCC (Agar et al., 2004). Of interest is
that the protection by 1,25(OH)2D of the formation of these
UVA fingerprint mutations may not require the VDR (Gordon-
Thomson et al., 2012), and the role of calcium in their formation
has not been studied.
THE HEDGEHOG (HH) PATHWAY IN
EPIDERMAL TUMOR FORMATION
Activation of HH signaling has been shown to result in BCC
in both animals and humans (Hahn et al., 1996), and appears
also to predispose to UVB induced SCC (Ping et al., 2001).
This was first demonstrated when PTCH1mutations were found
to be the cause of the basal cell nevus syndrome (BCNS)
(Gorlin Syndrome), a syndrome in which patients readily
develop BCCs (Hahn et al., 1996; Aszterbaum et al., 1998).
This syndrome has been reproduced in a mouse model with
Ptch1 mutations (Aszterbaum et al., 1999). Subsequently it
was found that essentially all BCCs, sporadic or part of the
BCNS, have mutations in PTCH1 or other elements of the
HH signaling pathway (Aszterbaum et al., 1998), and nearly
all BCC in humans or mice overexpress Ptch1 or one of the
other components of the HH pathway (Tojo et al., 1999; Bonifas
et al., 2001). A drug, vismodegib, targeting the HH pathway,
has recently been developed as the first effective non-surgical
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treatment for advanced BCC (Sekulic et al., 2012; Tang et al.,
2012).
In the basal state Ptch1 inhibits the function of smoothened
(Smo), like Ptch1 a membrane protein. Smo, in the inhibited
state, keeps the Gli family of transcription factors bound to
suppressor of fused (Sufu) within the cytoplasm, thus limiting
their translocation to the nucleus (Barnfield et al., 2005; Svärd
et al., 2006). Sonic hedgehog (Shh) binding to Ptch1 reverses its
inhibition of Smo enabling the release of the Gli factors from
Sufu and their entry into the nucleus. Gli1 and 2 are the main
actors in gene transcription (Mimeault and Batra, 2010). Their
transcriptional activity includes the increased expression of other
components of the HH pathway, as well as anti apoptotic and
cell cycle factors including Bcl2, Ccnd1,2, E2f1, Cdc45, thus
promoting proliferation, while suppressing genes associated with
keratinocyte differentiation including the VDR (Grachtchouk
et al., 2000; Nilsson et al., 2000; Regl et al., 2002, 2004a,b).
When Gli1, Gli2, or Shh are overexpressed in basal keratinocytes,
BCC develop (Oro et al., 1997; Grachtchouk et al., 2000; Nilsson
et al., 2000). Similarly human keratinocytes overexpressing Shh
develop BCC like lesions when grafted unto nudemice (Fan et al.,
1997).
Vdr null animals overexpress elements of the HH signaling
pathway in their epidermis (Teichert A. et al., 2011), although
they show reduced expression in the cycling portion of their
hair follicles (Teichert et al., 2010). Consensus sequences for
vitamin D response elements (VDRE) in the promoters of Shh,
Ptch1, Ptch2, Gli1, and Gli2 have been identified (Reddy et al.,
2004; Wang et al., 2005; Pálmer et al., 2008; Luderer et al.,
2011), and we (Teichert A. et al., 2011) have demonstrated
that 1,25(OH)2D inhibits their expression in a VDR dependent
fashion. Moreover, vitamin D per-se has been shown to suppress
Smo (Bijlsma et al., 2006; Tang et al., 2011), presumably by a non-
genomic mechanism. These findings in the epidermis stand in
stark contrast to the role of VDR during HF cycling where the
unliganded VDR appears to promote the ability of HH signaling
to initiate early anagen (Lisse et al., 2014).
β-CATENIN SIGNALING IN EPIDERMAL
TUMOR FORMATION
Benign hair follicle tumors, pilomatricomas or
trichofolliculomas, result from over activation of the wnt/β-
catenin pathway (Gat et al., 1998; Chan et al., 1999; Xia et al.,
2006). However, this depended on the VDR status of the animal.
Pálmer et al. (2008) demonstrated an interaction between
VDR and β-catenin in transcriptional regulation. They found
putative response elements for VDR and β-catenin /LEF1 in a
number of genes including those of the HH signaling pathway.
Moreover, an analog of 1,25(OH)2D could block the formation
of these hair follicle tumors induced by overactivation of the
wnt/β-catenin pathway. On the other hand, mice lacking VDR
developed BCC rather than the more benign trichofolliculomas
when the wnt/β-catenin pathway was overactivated. In humans
trichofolliculomas were found to have high nuclear levels of both
β-catenin and VDR, whereas BCC have high levels of β-catenin
but low levels of VDR (Pálmer et al., 2008). These data indicate
the importance of the interactions between VDR and β-catenin
in the hair follicle and in the epidermis in both mice and
humans. As in HH signaling, these interactions are complex in
that VDR is required for β-catenin activation in the hair follicle
(Lisse et al., 2014), such that when β-catenin transcriptional
activity is prevented as in the VDRKO, hair follicle formation is
blocked (Huelsken et al., 2001). On the other hand suppression
of β-catenin transcriptional activity by VDR in the epidermis
appears to be protective with respect to tumor formation (Wei
et al., 2007).
As noted earlier both the Casr and VDR are required for
the formation of the E-cadherin/catenin complex, which is not
only required for the differentiation of the keratinocyte, but by
keeping β-catenin bound to the membrane prevents its nuclear
translocation and activation of genes promoting proliferation.
Loss of the E-cadherin/catenin complex is a well-known marker
of malignant transformation in a number of epithelial cells
(Ghahhari and Babashah, 2015). Moreover, we (Tu et al., 2007;
Tu C.L. et al., 2008) have shown that deletion of the Casr from
keratinocytes reduces their stores of calcium and blocks their
response to extracellular calcium (Cao) including the formation
of the E-cadherin/catenin complex.
The β-catenin and HH pathways interact (Bienz, 2005;
Pálmer et al., 2008). Using a constitutively active Smo
[Gt(ROSA)26Sortm1(Smo/EYFP)Amc] in keratinocytes to induce
BCC, two groups (Yang et al., 2008; Youssef et al., 2012) found
a rapid increase in genes of the Wnt/ β-catenin pathway. Dkk1
overexpression or deletion of Ctnnb1 prevented the development
of BCC. Both HH andWnt/ β-catenin pathway constituents were
found to be over expressed in a series of human BCC (Youssef
et al., 2012). Putative β-catenin /LEF1 response elements as well
as VDRE mentioned earlier have been found in a number of
HH pathway genes (Pálmer et al., 2008), which unlike the VDRE
appear to be stimulated by activated β-catenin with an increase
in Shh expression (Schneider et al., 2010). The role of VDR in the
regulation of these two pathways is shown in Figure 1.
LONG NON-CODING RNAS (LncRNA)
Approximately 20,000 protein-coding genes are encoded by the
human genome. This represents less than 2% of the total genomic
sequence. That said 90% of the genome is actively transcribed
without protein coding potential (Mercer et al., 2009). These
non-coding transcripts are arbitrarily divided into short and long
non-coding RNAs with small non-coding RNAs defined as less
than 200 bases, including tRNAs, microRNAs, and small nuclear
(snoRNAs), and long non-coding RNAs (lncRNAs) as those with
lengths larger than 200 bases, some over 100 kb in length (Gibb
et al., 2011). Much of the transcriptome is comprised of lncRNAs
(∼80%; Mercer et al., 2009), and over 23,000 have been identified
so far. Like mRNAs they are spliced and contain polyadenylation
signals, (Mattick, 2011).Many regulatory processes are controlled
by lncRNAs including embryonic pluripotency, differentiation,
and body axis patterning, promoting developmental transitions
(Mattick, 2011; Batista and Chang, 2013). LncRNAs can influence
the epigenetic programs of the transcriptome through their
regulation of histone modifications (Spitale et al., 2013).
Of particular relevance to this review is that lncRNAs
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FIGURE 1 | Regulation of HH and Wnt/β-catenin signaling by 1,25(OH)2D/VDR and calcium/Casr. The keratinocyte expresses VDR and is capable of making
its own 1,25(OH)2D3 from the vitamin D3 produced from 7-dehydrocholesterol (DHC) under the influence of UVB, as it has both Cyp27a1/Cyp2r1 (which convert
vitamin D3 to 25OHD3) and Cyp27b1 [which converts 25OHD3 to 1,25(OH)2D3]. The keratinocyte also expresses the calcium sensing receptor Casr required for
calcium induced differentiation. 1,25(OH)2D/VDR suppresses Shh and Gli1 expression, inhibiting the HH pathway in keratinocytes. 1,25(OH)2D/VDR binds
CTNNB1(β-catenin) and increases CDH1(E-cadherin) levels in the plasma membrane reducing the amount of β-catenin available for binding to TCF/LEF in the nucleus
limiting its transcriptional activity. Calcium acting through its receptor is required for the formation of the E-cadherin/catenin complex in the plasma membrane. In
combination these actions reduce the proliferative actions of Shh and Wnt/β-catenin signaling in keratinocytes, limiting their ability to induce tumors in the skin.
regulate cancer development through a number of effects
on tumor cell proliferation, blocking growth suppressors,
inducing angiogenesis, and promoting invasion and metastasis
(Gibb et al., 2011; Gutschner and Diederichs, 2012; Li et al.,
2013).
We (Jiang and Bikle, 2014) evaluated the potential role of
lncRNAs in VDR protection against skin tumor formation using
in vitro cultured mouse keratinocytes and an in vivo mouse
model, comparing cell or mouse epidermis from wildtype or
Vdr null animals, in an array containing 90 well-annotated
mouse lncRNAs. We found increased expression of several
well-known oncogenes, including H19, HOTTIP, and Nespas,
and reduced expression of tumor suppressor genes such as
Kcnq1ot1, lincRNA-p21 in VDR deleted keratinocytes whether
from cultured cells or epidermis. These results point to an
additional mechanism for protection by VDR against skin cancer
formation that we are in the early stages of exploring. Whether
concomitant Casr deletion will amplify these results has not yet
been determined.
CONCLUSIONS
Both calcium and vitamin D signaling through their respective
receptors Casr and VDR are important for the normal functions
of the skin. In this article we have focused on their roles
in tumor development when such signaling is disrupted by
deletion of the receptors. At this point we have not observed
tumor formation in the skin of mice lacking only the Casr, but
have observed that mice lacking both Casr and VDR develop
tumors of greater malignancy and spontaneity than seen in
mice lacking only the VDR. Analyses of gene expression in the
epidermis from mice lacking one or both of these receptors
clearly demonstrate the synergism between VDR and Casr in
gene regulation including genes involved with cancer such as
the E-cadherin/catenin pathway that plays such an important
role in the epithelial/mesenchymal transition leading to tumor
formation. We have focused on two pathways, HH and Wnt/
β-catenin, that are regulated by VDR and Casr, and that
are plausible participants in epidermal tumor formation when
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their regulation is disrupted. In addition we have introduced
a new mechanism, alterations in lncRNA expression toward
an oncogenic profile, when VDR is deleted. No doubt other
pathways will emerge that contribute to a greater or lesser degree
to the predisposition of the epidermis lacking VDR and/or Casr
to tumor formation.
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